Simon JK, Staerke NB, Hemming-Harlo M, Layle S, et al. Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged >/=50 years: A randomized phase 3 trial (PNEU-TRUE). Vaccine 2022 Jan 13. pii: S0264-410X(21)01675.
PMID: 35039194